Journal article
P-TEFb goes viral
- Abstract:
- Positive transcription elongation factor b (P-TEFb), which comprises cyclin-dependent kinase 9 (CDK9) kinase and cyclin T subunits, is an essential kinase complex in human cells. Phosphorylation of the negative elongation factors by P-TEFb is required for productive elongation of transcription of protein-coding genes by RNA polymerase II (pol II). In addition, P-TEFb-mediated phosphorylation of the carboxyl-terminal domain (CTD) of the largest subunit of pol II mediates the recruitment of transcription and RNA processing factors during the transcription cycle. CDK9 also phosphorylates p53, a tumor suppressor that plays a central role in cellular responses to a range of stress factors. Many viral factors affect transcription by recruiting or modulating the activity of CDK9. In this review, we will focus on how the function of CDK9 is regulated by viral gene products. The central role of CDK9 in viral life cycles suggests that drugs targeting the interaction between viral products and P-TEFb could be effective anti-viral agents.
- Publication status:
- Published
- Peer review status:
- Peer reviewed
Actions
Access Document
- Files:
-
-
(Preview, Version of record, pdf, 969.1KB, Terms of use)
-
- Publisher copy:
- 10.1002/icl3.1037
Authors
+ Sir Edward Penley Abraham Trust Fund
More from this funder
- Funding agency for:
- Murphy, S
- Grant:
- EPA-RF202
- Publisher:
- Wiley
- Journal:
- Inside the Cell More from this journal
- Pages:
- n/a-n/a
- Publication date:
- 2015-01-01
- DOI:
- ISSN:
-
2375-2920
Terms of use
- Copyright holder:
- Zaborowska et al
- Copyright date:
- 2015
- Notes:
-
Copyright © 2015 The Authors. Inside the Cell published by WILEY Periodicals, Inc.
This is an open access article under the terms of the Creative Commons Attribution License, which permits use, distribution and reproduction in any medium, provided the original work is properly cited.
- Licence:
- CC Attribution (CC BY)
If you are the owner of this record, you can report an update to it here: Report update to this record